Pricing Supplement dated September 17, 1998                Rule
424(b)(3)
(To Prospectus dated August 19, 1997 and               File No.
333-32135
Prospectus Supplement dated August 19, 1997)

                   NATIONWIDE HEALTH PROPERTIES, INC.

                 Medium-Term Note, Series C - Fixed Rate
- ------------------------------------------------------------------
- ------
Face Amount: $25,000,000
Trade Date: September 16, 1998
Issue Price: 100%
Original Issue Date: September 21, 1998
Interest Rate: 7.375%
Net Proceeds to Issuer: $24,875,000
Interest Payment Dates: April 1, October 1
Agent's Commission:  0.50%
Regular Record Dates: March 17, September 16
Name of Agent: Merrill Lynch & Co.
Stated Maturity Date: September 22, 2003
Agent acting in the capacity indicated below:
 [X] As Agent
 [ ] As Principal
Denominations (if other than $1000 and integral multiples
thereof):_______________
- ------------------------------------------------------------------
- ------

Day Count Convention:
 [X] 30/360 for the period from September 21, 1998 to September
22, 2003
 [ ] Actual/360 for the period from                to
 [ ] Actual/Actual for the period from             to
 [ ] Other (see attached)                          to

Redemption:
 [X] The Notes cannot be redeemed prior to the Stated Maturity
Date.
 [ ] The Notes may be redeemed prior to Stated Maturity Date.
      Initial Redemption Date:
      Initial Redemption Percentage:     %
      Annual Redemption Percentage Reduction:      % until
Redemption
       Percentage is 100% of the Principal Amount.

Repayment:
 [X] The Notes cannot be repaid prior to the Stated Maturity Date.
 [ ] The Notes can be repaid prior to the Stated Maturity Date at
the
     option of the holder of the Notes.
      Optional Repayment Date(s):
      Repayment Price:   100%

Original Issue Discount: [ ]  Yes   [X]  No
 Total Amount of OID:
 Yield to Maturity:
 Initial Accrual Period:

Form: [X] Book-entry   [ ] Certificated
                 ------------------------------------------
          Goldman, Sachs & Co.                    Merrill Lynch &
Co.